JASE Call for Papers: Chamber Quantification

Submissions are due in Editorial Manager by June 1, 2025

The Journal of the American Society of Echocardiography (JASE) is pleased to announce a Call for Papers for a Focus Issue on Chamber Quantification for publication in early 2026. The issue will include ASE’s new guidelines on chamber quantification.

We invite submission of original research studies, reviews, letters, and brief research communications that address any aspect of echocardiography in quantitative assessment of the cardiac chambers. This may include

  • Technical tips and illustrations
  • Current challenges
  • Ethnic, racial, and sex differences in measurements
  • Effects of growth and aging
  • Functional/structural interdependence
  • Correlation with other imaging methods
  • Impact of new technologies
  • Impact of artificial intelligence
  • Relationship to outcomes
  • Future research goals

The guidelines document will include normal range values; additional work documenting such ranges is of less interest. In line with our core values at JASE, we welcome multi-disciplinary collaborations (e.g., sonographers, nurses, physicians, scientists) from all users of echocardiography.

Submissions are due in Editorial Manager by June 1, 2025: https://www.editorialmanager.com/jasecho/default1.aspx.
Please note in your cover letter that the submission is for the Chamber Quantification Issue.

ASE Announces 2024-2026 Leadership Academy Cohort

FOR IMMEDIATE RELEASE

Contact: Angie Porter
919-297-7152
APorter@ASEcho.org

American Society of Echocardiography Announces 2024-2026 Leadership Academy Cohort

The cohort will develop leadership skills to advance their careers and the cardiovascular ultrasound field

(DURHAM, NC, October 30, 2024)—The American Society of Echocardiography (ASE) is pleased to announce the 15 participants who will make up the fourth ASE Leadership Academy cohort. The 2024-2026 cohort was selected from a large pool of highly qualified candidates looking to grow and advance their careers in ASE and the field of cardiovascular ultrasound.

The cohort, which will have its first meeting on November 8-9 in Washington, D.C., will spend nearly two years training to develop their leadership skills. Members will be matched with a senior adviser and receive access to high-quality online tutorials on leadership topics orchestrated by Kathy Pearson, PhD—a strategist, systems thinking expert and authority in decision making. Additionally, participants will closely interact with fellow classmates, and meet face-to-face with ASE leaders and staff three times throughout the 20-month program.

The ASE Leadership Academy Oversight Committee, led by Program Director and ASE Past President Madhav Swaminathan, MD, MMCi, FASE, selected a diverse group made up of 12 physicians and three sonographers from 10 states. The individuals were chosen through an extensive peer review process by a panel of ASE leaders and are representative of the diverse population of ASE members.

“The ASE Leadership Academy is a remarkable program designed to build leadership capacity within the cardiovascular ultrasound community. The newly selected members will acquire essential leadership skills that will not only advance their careers but also elevate the field of cardiovascular ultrasound through their commitment to the specialty,” said Dr. Swaminathan, chair of the Department of Anesthesiology at Wake Forest University School of Medicine and Atrium Health Wake Forest Baptist in Winston-Salem, N.C.

“Ultimately, this program benefits the patients we all serve. Since its inception in 2018, 44 ASE members have graduated from the Leadership Academy and have already made significant contributions, gaining national and international recognition as experts in cardiovascular ultrasound,” he added.

2024-2026 ASE Leadership Academy Cohort 4:

  • Vidhu Anand, MBBS, FASE, Mayo Clinic Health System – Eau Claire, WI, and Mayo Clinic – Rochester, WI
  • Clara I. Angulo, BS, RDCS, MBA, ACS, FASE, Houston Methodist DeBakey Heart & Vascular Center – Houston, TX
  • Alicia Armour, BS, MA, ACS, RDCS, FASE, Duke Triangle Health Associates, Health Center – Durham, NC
  • Sowmya Balasubramanian, MD, MSc, FASE, C. S. Mott Children’s Hospital – Ann Arbor, MI
  • Anisiia Crowley, MD, FASE, University of Cincinnati Medical Center/UC Health – Cincinnati, OH
  • Ingrid Moreno Duarte, MD, FASE, UT Southwestern Medical Center – Dallas, TX
  • Lynsy Friend, BS, ACS, RCS, FASE, Dartmouth-Hitchcock Medical Center – Lebanon, NH
  • Joyce Johnson, MD, MS, FASE, Johns Hopkins All Children’s Hospital – Saint Petersburg, FL
  • Kyle Lehenbauer, MD, FASE, Saint Luke’s Hospital of Kansas City – Kansas City, MO
  • Andrew Peters, MD, FASE, Sidney Kimmel School of Medicine at Thomas Jefferson University – Philadelphia, PA
  • Nishath Quader, MD, FASE, Washington University School of Medicine – St. Louis, MO
  • Karl Richardson, MD, FASE, Wake Forest School of Medicine – Winston-Salem, NC
  • Jeremy Slivnick, MD, FASE, The University of Chicago Medicine – Chicago, IL
  • Parag Tipnis, MD, FASE, University of Wisconsin School of Medicine & Public Health – Madison, WI
  • Betul Yilmaz, MD, FASE, Texas Children’s Hospital, Baylor College of Medicine – Houston, TX

The ASE Leadership Academy program creates a pipeline of emerging leaders with specific talents to help them succeed as ASE leaders and volunteers, and in roles with other organizations and institutions. Their leadership skills will propel the future of the Society, which celebrates its milestone 50th Anniversary in 2025. Learn more at ASEcho.org/LeadershipAcademy.

About American Society of Echocardiography
The American Society of Echocardiography (ASE) is the Society for Cardiovascular Ultrasound Professionals™. ASE is the largest global organization for cardiovascular ultrasound imaging serving physicians, sonographers, nurses, veterinarians, and scientists and as such is the leader and advocate, setting practice standards and guidelines for the field. The Society is committed to advancing cardiovascular ultrasound to improve lives. For more information, visit the ASE website ASEcho.org or social media accounts on Facebook, X (formerly Twitter), LinkedIn, or Instagram.

###

CASE Sonographer Challenge

ATTENTION, SONOGRAPHERS – Do you have a great case report you’d like to publish?
Now is the time to submit it to CASE!

To highlight the importance of the work that cardiovascular ultrasound sonographers do every day, CASE is holding a brief Sonographer Challenge. The first 5 papers submitted by October 25 with a sonographer as the lead author (first or corresponding) will be eligible to receive a full waiver of the Article Processing Fee if accepted by December 10 (up to $950 per accepted case). In order to receive the waiver, the submission must be accepted by December 10, 2024, so revisions would need to be made in a timely manner.

Please share this Sonographer Challenge with your colleagues and encourage them to submit to CASE. Email Debbie Meyer, Director of Publications (JASE, CASE), or Andie Piddington, Deputy Managing Editor (JASE, CASE), with any questions.

ASE at TCT2024

Join ASE and CRF on Monday, October 28, for a special joint session at TCT® titled Innovation 6: Disruptive Imaging Concepts in Valvular Heart Disease. Topics will highlight novel imaging concepts and include ASE expert discussion of each topic. This session underpins the essential role echocardiography and imaging play in diagnosing, treating, and monitoring valve disease. Innovative in nature, this session will provide insight of what imaging in valvular heart disease might look like in the future.

Monday, October 28
Innovation 6: Disruptive Imaging Concepts in Valvular Heart Disease
4:50 PM – 5:50 PM
Room:
 Innovation Theater, Innovation & Exhibit Hall (Halls A-C), Lower Level, Walter E. Washington Convention Center
SPONSORED by the American Society of Echocardiography (ASE) in Partnership with CRF®

Moderators: Omar Khalique, MD, FASE; Fabien Praz, MD
Discussants: Julia Grapsa, MD, PhD, FASE; Renuka Jain, MD, FASE; Chad Kliger, MD; Alexander Lauten, MD, PhD; Stephen Little, MD, FASE; Nishath Quader, MD, FASE;
Alternates: Lin Wang, MD, MS, FASE; Lucy Safi, DO, FASE; Laura Sanchis; Joao Cavalcante, MD, FASE; Nadeen Faza, MD, FASE; Enrique Garcia-Sayan, MD, FASE

Video game or Interventional echo? Augmented Reality and Holography in Imaging for Structural Heart Disease
4:50 PM – 4:58 PM
Mark Lebehn

Discussion
4:58 PM – 5:05 PM

Pulmonary Artery Pulsatility Index in Patients Undergoing Transcatheter Tricuspid Valve Interventions (67510)
5:05 PM – 5:12 PM
Guillaume Bonnet

Discussion
5:12 PM – 5:17 PM

Predicting Outcomes in Patients Undergoing TTVr for Severe TR: Role of Right Ventricular Free Wall Longitudinal Strain-Derived Pulmonary-Arterial Coupling (68898)
5:17 PM – 5:24 PM
Jennifer von Stein

Discussion
5:24 PM – 5:28 PM

Regurgitant Fraction Quantified by Liver Mapping Analysis Using Cardiac Magnetic Resonance Predict Outcomes in a Large Cohort of All-Comers Patients with Chronic Tricuspid Regurgitation (65598)
5:28 PM – 5:35 PM
Davide Margonato

Discussion
5:35 PM – 5:40 PM

A Novel Doppler-Based Technology for the Non-Invasive Analysis of Cardiac Hemodynamics (Diagnics) (69122)
5:40 PM – 5:47 PM
Zahra K. Motamed

Discussion
5:47 PM – 5:50 PM

A Standout September CASE

The latest issue of CASE is now available with intriguing reports, including “Multidirectional Blood Flow During Cardiopulmonary Bypass Mimicking an Iatrogenic Aortic Dissection During Transesophageal Echocardiographic Examination.” CASE Editor-in-Chief Vincent Sorrell, MD, FASE, remarked, “Foster et al. remind us all of one of the very important reasons this Journal has been such a success to our Society. These authors elegantly describe a common finding during cardiopulmonary bypass that may result in potentially devastating clinical consequences when not recognized. They performed a series of basic scientific steps to solve the root cause for understanding an image that initially appeared to be an aortic dissection. In doing so, they describe the pattern of multidirectional blood flow within the aorta that accompanies bypass cannulation. Next, they demonstrate the change in Doppler findings when the bypass flow is held. Lastly, they include post-operative tomographic imaging for further education. Readers unfamiliar with this finding may be spared an unnecessary poor outcome. Other readers may use this approach as a guide to their own CASE report when they are confronted with an echo/Doppler artifact.”

A second Intraoperative Echocardiography report follows the sequence of intraoperative clinical events that resulted in severe hypoxemia during aortic valve surgery, using TEE as a primary investigative tool. In the Congenital Heart Disease category, Fahim et al. expound upon their echo findings in an adult with a double-chambered right ventricle, including excellent correlative CMR images to enhance their echo insights. The next case highlights the critical value of peripheral ultrasound with a patient whose pseudoaneurysm found on vascular ultrasound uniquely had a second pseudoaneurysm evolving from the first. Just Another Day in the Echo Lab rounds out this issue with a reminder that serial TEE is crucial after placement of a left atrial appendage occlusion device.

Be sure to read Dr. Sorrell’s editorial as he shares insights from patients on how to better engage them in the echo process, so they can feel like informed, active participants in their progression of care.

Looking for a journal to submit your case report to? We want to hear from you!
Email us with questions or submit your report today.

ASE Publishes Updated Guideline to Improve Care for HF Patients with Implanted Medical Devices

FOR IMMEDIATE RELEASE

Contact: Angie Porter
919-297-7152
APorter@ASEcho.org

ASE Publishes Updated Guideline to Improve Care for Heart Failure Patients
with Implanted Medical Devices

(DURHAM, NC, September 10, 2024)—A new guideline from the American Society of Echocardiography (ASE) aims to provide more detail on the best imaging strategies for managing and improving care for heart failure patients with surgically implanted left ventricular assist devices (LVADs) and temporary mechanical circulatory support (TMCS) devices.

Advances over the past several years prompted the need for an updated perspective on the role of echocardiography and multimodality imaging to evaluate and manage potential complications associated with temporary and durable LVADs and TMCS devices. Recommendations for Multimodality Imaging of Patients with Left Ventricular Assist Devices and Temporary Mechanical Support: Updated Recommendations from the American Society of Echocardiography is an update to the Society’s original guideline published in 2015.

“This new guideline document serves as an update to the 2015 comprehensive ASE LVAD guideline. We provide detailed information and recommendations on TMCS devices, and we define the contemporary role of echocardiography and multimodality imaging in patient selection, pre-intra-and post-procedural surveillance, and troubleshooting with focus on the HM3 LVAD,” said lead author Dr. Jerry Estep, the Division Chair of Cardiovascular Medicine at Cleveland Clinic Florida in Weston. “We hope the framework we provide will improve patient outcomes by providing the best imaging strategies before and after durable and temporary device implantation.”

Many principles and recommendations detailed in ASE’s original 2015 guideline are still current and valid, and this updated document includes several of the previously published key points for the use of echocardiography. Additionally, it addresses new devices, expands upon the role of multimodality imaging and acknowledges the growing role of point-of-care ultrasound in evaluating patients with mechanical circulatory support. The writing group includes experts from multiple disciplines who hope the document will encourage future studies to continue advancing the field.

The new guideline is published in the September 2024 issue of the Journal of the American Society of Echocardiography. All guidelines published by ASE are available at ASEcho.org/Guidelines.

About American Society of Echocardiography
The American Society of Echocardiography (ASE) is the Society for Cardiovascular Ultrasound Professionals™. ASE is the largest global organization for cardiovascular ultrasound imaging serving physicians, sonographers, nurses, veterinarians, and scientists and as such is the leader and advocate, setting practice standards and guidelines for the field. The Society is committed to advancing cardiovascular ultrasound to improve lives. For more information, visit the ASE website ASEcho.org or social media pages on Facebook, X (formerly Twitter), LinkedIn, or Instagram.

###

New ASE Guideline Clarifies Cardiac POCUS Nomenclature

FOR IMMEDIATE RELEASE

Contact: Angie Porter
919-297-7152
APorter@ASEcho.org

New ASE Guideline Clarifies Cardiac Point-of-Care Ultrasound Nomenclature
The guideline aims to standardize the nomenclature around cardiac point-of-care ultrasound to facilitate collaboration, reduce confusion and enhance patient safety

(DURHAM, NC, September 10, 2024)—A new guideline from the American Society of Echocardiography (ASE) addresses the ambiguity in the current terminology used for cardiac point-of-care ultrasound (POCUS).

The guideline, titled Recommendations for Cardiac Point-of-Care Ultrasound Nomenclature, outlines specific recommendations establishing a deliberate vocabulary of cardiac POCUS-related terms to improve consistency in patient-care and research settings.

Clinicians use cardiac POCUS to examine heart and vascular systems at a patient’s bedside. However, because this diagnostic tool is utilized by a multitude of clinicians from numerous specialties in different settings, there are currently inconsistencies in the language and terms surrounding cardiac POCUS.

“Many terms have been proposed to describe the use of ultrasound by bedside clinicians to image the heart, and the words we use matter,” said Chair of the Guideline Writing Group Dr. James N. Kirkpatrick, Professor of Medicine and Bioethics and Humanities, and Director of the Echocardiography Laboratory at the University of Washington Medical Center in Seattle. “We believe our recommended terms and definitions can be an important step in bringing together the different specialties that use cardiac POCUS to standardize what we do—all for the good of the patient.”

The writing group is co-chaired by Dr. Nova Panebianco, Professor of Emergency Medicine and Director of Emergency Ultrasound at the University of Pennsylvania, and Dr. Jose Luis Diaz-Gomez, Institute Chair—Integrated Hospital Care at Cleveland Clinic Abu Dhabi and Adjunct Professor of Anesthesiology at Baylor College of Medicine. Additionally, it includes healthcare professionals from multiple stakeholder medical societies and a specialist in medical linguistics.

The guideline focuses on four main areas:

  1. Review the evolution of cardiac POCUS-related terms.
  2. Outline specific recommendations, distinguishing between intrinsic and practical differences in ‘‘basic cardiac POCUS/FoCUS,’’ ‘‘advanced cardiac POCUS,’’ ‘‘consultative echocardiography,’’ and ‘‘ultrasound assisted physical examination.’’
  3. Address implications of these recommendations for current practice.
  4. Discuss the implications for novel technologies and future research.

Drs. Kirkpatrick, Panebianco and Diaz-Gomez believe that a standard nomenclature can set the stage for future consensus building around the coordination of imaging studies, credentialing processes, billing practices, liability considerations, training protocols, and research.

“We intend for this cardiac POCUS nomenclature to be a starting point for future work in more specific areas. Establishing a deliberate vocabulary is the foundation for the accurate and efficient transfer of medical knowledge among healthcare professionals, educators, administrators, insurance providers, credentialing bodies, and most importantly, patients,” Dr. Kirkpatrick commented.

This document is endorsed by the American College of Chest Physicians (CHEST), the American College of Emergency Physicians (ACEP), the American Institute of Ultrasound in Medicine (AIUM), the American Thoracic Society (ATS), the Society of Critical Care Medicine (SCCM), World Interactive Network Focused on Critical Ultrasound (WINFOCUS) and 26 ASE International Alliance Partners.

The new guideline is published in the September 2024 issue of the Journal of the American Society of Echocardiography. All guidelines published by ASE are available at ASEcho.org/Guidelines.

About American Society of Echocardiography
The American Society of Echocardiography (ASE) is the Society for Cardiovascular Ultrasound Professionals™. ASE is the largest global organization for cardiovascular ultrasound imaging serving physicians, sonographers, nurses, veterinarians, and scientists and as such is the leader and advocate, setting practice standards and guidelines for the field. The Society is committed to advancing cardiovascular ultrasound to improve lives. For more information, visit the ASE website ASEcho.org or social media pages on Facebook, X (formerly Twitter), LinkedIn, or Instagram.

###

The Heart of Summer: July JASE

The July issue of JASE includes, “Cardiac Structural Changes and Declining Cardiorespiratory Fitness During Androgen Deprivation Therapy for Prostate Cancer.” Author Timothy W. Churchill, MD, FASE, remarks, “We studied men initiating treatment with androgen deprivation therapy (ADT) for prostate cancer using echocardiography and cardiopulmonary exercise testing at baseline and after six months of therapy. Over this time, we saw decreases in LV wall thickness and LV mass, and with these, exercise capacity, as measured by peak VO2, also declined. While preliminary, these findings raise the possibility that ADT, known for its associated skeletal muscle sarcopenia, could also be associated with similar myocardial changes that, paired with observed decreases in functional capacity, may have possible important prognostic implications.”

In addition to this report, readers can look forward to five other brief research communications on an array of topics. This issue hosts a variety of clinical investigations, as well, on topics ranging from AI in assessment of regional wall motion, to LV strain and prognosis in myocardial infarction, to 3D echo of the RV, and impact of cuff blood pressure measurement on myocardial work parameters. Three editorial comments accompany these papers, followed by a state-of-the-art review on radiation exposure to interventional echocardiographers and sonographers. Rounding out this issue are two letters to the editor.

In his first President’s Message, Theodore Abraham, MD, FASE, presents his vision for his term with three key initiatives to strengthen the Society for the next 50 years: ASE Creates, ASE Secures, and ASE Partners.

Check out our Author Spotlight page for a deeper dive into published works, including recent paper, “Echocardiographic Detection of Regional Wall Motion Abnormalities Using Artificial Intelligence Compared to Human Readers.”

Additionally, the 2023 Impact Factors were recently released. The new JASE Impact Factor is 5.4. There are 220 journals in the cardiac and cardiovascular systems category, and JASE maintained a high rank – 36 of 220 journals, keeping JASE in the top tier.

Please see the July ASE Education Calendar for a listing of educational opportunities far and wide.

ASE Appoints 2024-2025 President

FOR IMMEDIATE RELEASE

Contact: Angie Porter
919-297-7152
APorter@ASEcho.org

American Society of Echocardiography Appoints 2024-2025 President

(DURHAM, NC, July 1, 2024)—The American Society of Echocardiography (ASE) is pleased to announce the appointment of Theodore Abraham, MD, FASE, as the organization’s new President, effective July 1, 2024.

2024-2025 ASE President Theodore Abraham, MD, FASE

During the 35th Annual Scientific Sessions in Portland, Ore., June 14-16, Dr. Abraham shared his vision as the 2024-2025 ASE President. He will lead the global cardiovascular ultrasound imaging society during its milestone 50th anniversary in 2025, and he said that while it is important to celebrate the last 50 years, it is the future 50 years that will be top of mind during his Presidency.

Dr. Abraham plans to focus on three initiatives that he sums up as (1) ASE Creates, (2) ASE Secures, and (3) ASE Partners. ASE Creates is intended to awaken creativity within the Society and determine potential opportunities for innovation and invention in the field. ASE Secures will safeguard the Society’s future by identifying new technologies and education, and ASE Partners will concentrate on collaboration and help ASE continue building relationships with complementary partners, disciplines and organizations.

“ASE has been my professional home for more than 20 years. In my term as President, I am looking forward to embracing the Society’s rich 50-year history while also ensuring we remain at the forefront of innovation and excellence,” said Dr. Abraham. “It is an honor to represent our members and have a role in advancing and growing both ASE and the field of cardiovascular ultrasound to meet the needs of patients.”

Since first joining ASE in 2003, Dr. Abraham has held numerous leadership and volunteer positions on committees, task forces, writing groups and editorial boards. Some of his involvements and achievements include serving as Chair of ASE’s Membership Committee, earning Fellowship status in 2004, delivering the 2016 Feigenbaum Lecture at the 27th Annual ASE Scientific Sessions, receiving the 2018 Richard Popp Excellence in Teaching Award and supporting the ASE Foundation. Most recently, he chaired two ASE Hypertrophic Cardiomyopathy (HCM) forums in 2023 and 2024, and completed his term as the 2023-2024 President-Elect on the ASE Board of Directors’ Executive Committee.

Dr. Abraham earned his medical degree from Goa Medical College at the University of Bombay. He completed an internal medicine residency and an echocardiography research fellowship at Wake Forest University in Winston-Salem, N.C. Dr. Abraham then completed fellowships in clinical cardiology and echocardiography at the University of Texas Southwestern Medical Center in Dallas, Texas, and advanced echocardiography and muscle physiology at the Mayo Clinic in Rochester, Minn. After previous appointments at Mayo Clinic and Johns Hopkins University, he is currently a cardiologist and Meyer Friedman Distinguished Professor at the University of California San Francisco, where he also serves as the institution’s Adult Cardiac Echocardiography Laboratory Director and HCM Center of Excellence Co-director.

ASE membership also elected 11 new Board of Director members to serve the Society starting July 1, 2024. The ASE Executive Committee welcomes Vice President Cynthia Taub, MD, MBA, FASE, SUNY Upstate Medical University, Syracuse, N.Y., who will serve a one-year term. The new Treasurer serving a three-year term will be Akhil Narang, MD, FASE, Northwestern Medicine, Chicago, Ill. Secretary Melissa Wasserman, RDCS, RCCS, FASE, Children’s Hospital of Philadelphia, Philadelphia, Pa., and Council Representative Kelly Thorson, DHSc, MSRS, ACS, RDCS, RCCS, CIIP, FASE, Lucile Packard Children’s Hospital Stanford, Palo Alto, Calif., will each serve two-year terms.

The following new Board members were elected to serve two-year terms: Kristen Billick, BS, ACS, RCS, RDCS (AE, PE) FASE, Scripps Clinic and La Jolla Hospital, La Jolla, Calif. (Member at Large); Allyson Boyle, MHA, ACS, RDCS, FASE, Sanger Heart and Vascular Institute – Atrium Health, Charlotte, N.C. (Cardiovascular Sonography Council Chair); Tony Forshaw, M Cardiac Ultrasound, B Ex Sci, AMS (Cardiac), FASE, Queensland University of Technology Queensland, Australia (International Representative); Jennifer Liu, MD, FASE, Memorial Sloan Kettering Cancer Center, New York, N.Y. (Member at Large); Kameswari Maganti, MD, FASE, Rutgers Robert Wood Johnson Medical School, New Brunswick, N.J. (Member at Large); Nishath Quader, MD, FASE, Washington University in St. Louis, St. Louis, Mo. (Interventional Echocardiography Council Chair); and Matthew Vorsanger, MD, FACC, RPVI, FASE, NYU Grossman School of Medicine, New York, N.Y. (Circulation & Vascular Ultrasound Council Chair).

Founded in 1975, ASE currently has nearly 17,000 members across 112 countries. Learn more by visiting, ASEcho.org.

About American Society of Echocardiography
The American Society of Echocardiography (ASE) is the Society for Cardiovascular Ultrasound Professionals™. ASE is the largest global organization for cardiovascular ultrasound imaging serving physicians, sonographers, nurses, veterinarians, and scientists and as such is the leader and advocate, setting practice standards and guidelines for the field. The Society is committed to advancing cardiovascular ultrasound to improve lives. For more information visit ASE’s website ASEcho.org or social media pages on Facebook, X (formerly Twitter), LinkedIn, or Instagram.

###

ASE 2024 Research Spotlight 4

FOR IMMEDIATE RELEASE
Contact: Angie Porter
919-297-7152
APorter@ASEcho.org

Echocardiography Plays an Important Role in Identifying Risk of Future Hypertension in Preeclampsia Patients

(DURHAM, NC, June 14, 2024)—Research that will be presented at the American Society of Echocardiography’s 35th Annual Scientific Sessions, June 14-16, 2024, in Portland, Oregon, will share how echocardiography can be used to help predict the future development of hypertension in women who had preeclampsia during pregnancy.

Preeclampsia, a condition characterized by high blood pressure and organ damage during pregnancy, affects numerous women worldwide. After giving birth, some women who experienced preeclampsia are at an increased risk of developing hypertension. However, accurately identifying those at risk can be challenging, and there is currently limited research on how echocardiographic changes influence outcomes.

The research study, titled “Echocardiographic Parameters Associated with Future Hypertension in Patients with Preeclampsia,” intended to address that knowledge gap by utilizing echocardiography performed in the first three months post-preeclampsia to identify specific findings that could indicate an increased risk of high blood pressure in the future.

Researchers retrospectively examined echocardiographic predictors, such as left ventricular mass index (LVMi) and increased interventricular septal thickness (IVSD), as parameters for future diagnosis of hypertension. Out of the 252 women included in the study, which was conducted at Allegheny Health Network in Pittsburgh, Penn., nearly 50 percent were subsequently diagnosed with hypertension during follow-up within 2.3 years.

“Our study used echocardiography to check for specific findings that could identify women who might be at higher risk for high blood pressure after preeclampsia,” said lead author Dr. Anushree Puttur, a resident physician at the Allegheny Health Network. “By finding these clues, we hope to improve how we monitor and care for women after they’ve had preeclampsia.”

ASE 2024 will feature more than 450 abstract presentations showcasing cutting-edge research on the latest advances in cardiovascular ultrasound and cases illustrating breakthroughs in patient care. This research study will be presented as a rapid-fire abstract presentation on Saturday, June 15, from 4:00 to 5:00 p.m. at the Oregon Convention Center. Learn more about ASE 2024 and download the conference’s final event program at ASEScientificSessions.org.

About American Society of Echocardiography
The American Society of Echocardiography (ASE) is the Society for Cardiovascular Ultrasound Professionals™. ASE is the largest global organization for cardiovascular ultrasound imaging serving physicians, sonographers, nurses, veterinarians, and scientists and as such is the leader and advocate, setting practice standards and guidelines for the field. The Society is committed to advancing cardiovascular ultrasound to improve lives. For more information visit ASE’s website ASEcho.org or social media pages on Facebook, X (formerly Twitter), LinkedIn, or Instagram.

###